2014
DOI: 10.1212/wnl.0000000000000823
|View full text |Cite
|
Sign up to set email alerts
|

Directional steering

Abstract: This study provides Class IV evidence that for patients with Parkinson disease, steering DBS current is well tolerated, increases the threshold for side effects, and may improve the therapeutic window of subthalamic nucleus DBS as compared with current standard spherical stimulation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
167
2
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 219 publications
(181 citation statements)
references
References 15 publications
6
167
2
2
Order By: Relevance
“…The idea of directional stimulation [5,19] has been extensively researched, and new leads [6,31] [10], but also on EMG and acceleration signals of tremor [3]. For such technologies to be practically useful and rapidly applicable, intraoperative quantitative evaluations of disease manifestations such as tremor and rigidity might play an important role.…”
Section: Discussionmentioning
confidence: 99%
“…The idea of directional stimulation [5,19] has been extensively researched, and new leads [6,31] [10], but also on EMG and acceleration signals of tremor [3]. For such technologies to be practically useful and rapidly applicable, intraoperative quantitative evaluations of disease manifestations such as tremor and rigidity might play an important role.…”
Section: Discussionmentioning
confidence: 99%
“…6 Directional leads-within limits-may address these issues, allowing stimulation to be directed toward the functional target and away from side-effect structures. As such, these novel leads can widen the therapeutic window by lowering the efficacy threshold and increasing the side-effect threshold, 10,11 as indicated in a recent pilot study. 12 A larger therapeutic window allows greater programming flexibility, as the expected beneficial effects of DBS may be reached at a lower current amplitude or higher current amplitudes could be attainable before side effects appear 11 -this is important when increasing the stimulation amplitude to optimize DBS efficacy during follow-up.…”
Section: Clinical Opportunitiesmentioning
confidence: 99%
“…12 A larger therapeutic window allows greater programming flexibility, as the expected beneficial effects of DBS may be reached at a lower current amplitude or higher current amplitudes could be attainable before side effects appear 11 -this is important when increasing the stimulation amplitude to optimize DBS efficacy during follow-up. 13 When used chronically, directional DBS may reduce the incidence of side effects that cannot be tested intraoperatively (eg, gait, cognitive, or behavioral disturbances) 10 and in patients with a narrow therapeutic window despite good location of the lead as verified by intraoperative testing, microrecordings, or imaging, as well as in patients operated under general anesthesia precluding clinical testing (eg, for dysarthria). By using a directional lead, it may thus be possible to improve outcomes and cause fewer adverse effects, including dyskinesia in patients with low thresholds for stimulation-induced dyskinesia.…”
Section: Clinical Opportunitiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Directional stimulation due to the independent activation of segmented electrodes allows for increased side-effect thresholds, and thus expands the therapeutic window [2-6]. However, without detailed knowledge about the lead’s orientation with regard to the patient’s anatomy, programming directional DBS settings relies on tedious and cumbersome trial and error processes.…”
Section: Introductionmentioning
confidence: 99%